Scientists probe JAK Drugs' hidden impact on immune cells in arthritis
NCT ID NCT03755297
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 31 times
Summary
This study looked at whether JAK inhibitors, a type of drug for rheumatoid arthritis, can boost the anti-inflammatory activity of certain immune cells called B cells. Researchers tested this in lab experiments using blood samples from 27 adults with rheumatoid arthritis. The goal was to understand how these drugs work on the immune system, not to directly treat patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Montpellier
Montpellier, 34, France
Conditions
Explore the condition pages connected to this study.